RedHill Biopharma Announces Insider Buying

TEL-AVIV, Israel & RALEIGH, N.C, Oct. 18, 2021 — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that members of its board of directors and senior management, including the Company’s Chairman & CEO, CFO, Chief Commercial Officer, Chief Business Officer and Chief Corporate & Business Development Officer, collectively purchased approximately 180,000 American Depositary Shares (ADSs) of RedHill between mid-September and October 15, 2021 in open-market transactions.

Tags: < Invest | M&A

RedHill Biopharma Announces Insider Buying

Related Industries

Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area

GE Healthcare showcases innovations designed to build cardiology care of the future at TCT2022

GE Announces Board of Directors for Future Independent GE HealthCare; Confirms Target Spin-Off Timing of First Week of January 2023

BD Appoints Two Business Unit Presidents

Honeywell To Collaborate With Leading Health Providers To Advance Digitalization Of Healthcare Globally

DSM completes acquisition of Prodap

Sabic Spotlights At The Battery Show North America Its Broad Portfolio For Advancing Ev Battery Sustainability, Efficiency & Safety

Henkel acquires Thermexit business from Nanoramic

ExxonMobil to sell its share of Aera Energy joint venture

PepsiCo, ADM Announce Groundbreaking Agreement Aiming to Reduce Carbon Intensity by Supporting Regenerative Agriculture Practices on Up to 2 Million Acres of Farmland

Ford Motor Company Partners with Climate Museum to Call Attention to Impacts of Climate Change Through Live Art Installation

Kohler Co. Elects Current President and Chief Executive Officer David Kohler as Chair and Chief Executive Officer

BD Appoints Two Business Unit Presidents

Hitachi Vantara Opens Application Reliability Center in Dallas

Intel and Broadcom Achieve Major Wi-Fi 7 Industry Milestone

INDUSTRIES

CONTACT US